NCT00894686 - Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) | Biotech Hunter

Enrollment

179

Participants

Timeline

Start Date

April 26, 2009

Primary Completion Date

May 10, 2017

Study Completion Date

May 10, 2017

Conditions

Encephalitis, Tick-Borne

Interventions

BIOLOGICAL

FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)

Dosage form: solution/suspension; injectable. Dosage frequency: once. Mode of administration: intramuscular.

Trial Locations (4)

Grieskirchnerstr.17, Oberösterreich

Untergraben 2, Oberösterreich

Dr. Ulrich Behre, Baden-Württemberg

Niepubliczny Zakład Opieki Zdrowotnej Ośrodek Zdrowia w Lipsku, Zamość